BridgeMD
New treatment option for Atrial Fibrillation (AF)
Official title Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters
ClinicalTrials.gov ID: NCT07130773
What this study is testing
- What it's testing
- The FARAPULSE PFA catheter (Boston Scientific), a first-generation Pulsed Field Ablation (PFA) tool, has demonstrated good performance in isolating pulmonary veins (PV). Several centers, including ours, utilize pre-procedural computer tomography (CT) to evaluate individual pulmonary vein anatomy and optimize ablation planning.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Atrial fibrillation (AF) documented on a 12-lead ECG, Holter monitor, or implantable cardiac device.
- Candidate for ablation according to current atrial fibrillation guidelines.
- Age ≥18 years at the time of informed consent.
- Signed informed consent obtained
You likely can't join if
- Previous left atrial ablation or left atrial surgery.
- Presence of intracardiac thrombus.
- Persistent atrial fibrillation lasting \>3 years.
- Severe mitral regurgitation or moderate-to-severe mitral stenosis.
- Pregnancy (all women under 50 years undergo an HCG blood test prior to inclusion to exclude pregnancy).
The study team makes the final eligibility decision.
Where it's taking place
- Lugano, Canton Ticino, Switzerland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lugano, Canton Ticino, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.